A retrospective cohort study was performed of the Hospital-to-Home (H2H) program, a rapid clinic follow-up program for patients with recent heart failure (HF) admissions at the University of Virginia Health System. There were 6761 hospitalizations among 4685 patients (age 67.5 ± 14.2 years, 43.9% female), and 759 had H2H follow-up. Thirty day mortality after the initial HF hospitalization was lower in H2H patients (1.84% vs 3.13%; P = .049), and this difference remained significant after adjustment in a multivariable logistic regression model (odds ratio = 0.56 [95% CI = 0.31-099]; P = .046). There also was a 24% reduction in readmission days within the first 30 days after the index admission (P < .0001), and readmission cost savings were found to be greater than the costs of staffing the H2H clinic. In summary, the H2H program is cost-effective, with significant improvements in survival, readmission days, and readmission costs over 30 days.
AllaFZannadFFilippatosG.Epidemiology of acute heart failure syndromes. Heart Fail Rev. 2007;12:91-95.
2.
TrogdonJGFinkelsteinEANwaiseIATangkaFKOrensteinD.The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract. 2007;8:234-242.
3.
MozaffarianDBenjaminEJGoASet al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
4.
HeidenreichPASahayAMittmanBSet al. Facilitation of a multihospital community of practice to increase enrollment in the hospital to home national quality improvement initiative. Jt Comm J Qual Patient Saf. 2015;41:361-369.
5.
ButlerJKalogeropoulosA.Hospital strategies to reduce heart failure readmissions: where is the evidence?J Am Coll Cardiol. 2012;60:615-617.
6.
VanSuchMNaessensJMStroebelRJHuddlestonJMWilliamsAR.Effect of discharge instructions on readmission of hospitalised patients with heart failure: do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care?Qual Saf Health Care. 2006;15:414-417.
7.
MetraMGheorghiadeMBonowRODei CasL.Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation. 2010;122:1782-1785.
8.
DunlaySMGheorghiadeMReidKJet al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010;12:367-374.
9.
VaduganathanMBonowROGheorghiadeM.Thirty-day readmissions: the clock is ticking. JAMA. 2013;309:345-346.
10.
CavesPKSchulzWPDongEJrStinsonEBShumwayNE.New instrument for transvenous cardiac biopsy. Am J Cardiol. 1974;33:264-267.
11.
HernandezAFGreinerMAFonarowGCet al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303:1716-1722.
12.
EinbinderJSScullyKWPatesRDSchubartJRReynoldsRE.Case study: a data warehouse for an academic medical center. J Healthc Inf Manag. 2001;15:165-175.
13.
ScullyKWPatesRDDesperGSet al. Development of an enterprise-wide clinical data repository: merging multiple legacy databases. Proc AMIA Annu Fall Symp. 1997:32-36.
14.
PatesRDScullyKWEinbinderJSet al. Adding value to clinical data by linkage to a public death registry. Stud Health Technol Inform. 2001;84:1384-1388.
15.
AustinPC.Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228-1234.
16.
CheungYB.Zero-inflated models for regression analysis of count data: a study of growth and development. Stat Med. 2002;21:1461-1469.
17.
DiehrPYanezDAshAHornbrookMLinDY.Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125-144.
18.
SolomonSDDobsonJPocockSet al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482-1487.
19.
JencksSFWilliamsMVColemanEA.Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428.
20.
LumHDStudenskiSADegenholtzHBHardySE.Early hospital readmission is a predictor of one-year mortality in community-dwelling older Medicare beneficiaries. J Gen Intern Med. 2012;27:1467-1474.
21.
SetoguchiSStevensonLWSchneeweissS.Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266.
22.
GheorghiadeMFilippatosGDe LucaLBurnettJ.Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(suppl 1):S3-S10.
23.
AmbrosyAPPangPSKhanSet al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34:835-843.
24.
LucasCJohnsonWHamiltonMAet al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140:840-847.
25.
LogeartDThabutGJourdainPet al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635-641.
26.
YancyCWJessupMBozkurtBet al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810-1852.
27.
O’ConnorCMMillerABBlairJEet al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010;159:841-849.e1.
28.
FeltnerCJonesCDCeneCWet al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2014;160:774-784.
FonarowGCAbrahamWTAlbertNMet al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43-51.
31.
FonarowGCAbrahamWTAlbertNMet al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61-70.
32.
GheorghiadeMVaduganathanMFonarowGCBonowRO.Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61:391-403.
33.
ChangPPChamblessLEShaharEet al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2014;113:504-510.
34.
KonstamMAGheorghiadeMBurnettJCJret al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319-1331.
35.
BradleyEHCurryLHorwitzLIet al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6:444-450.
36.
FonarowGCKonstamMAYancyCW.The hospital readmission reduction program is associated with fewer readmissions, more deaths: time to reconsider. J Am Coll Cardiol. 2017;70:1931-1934.
37.
GuptaAAllenLABhattDLet al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3:44-53.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
